CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Shares withheld for taxes Niedzwiecki Daniel gave up 243 shares (to pay taxes)
- 4 Open-market sale President & CEO sold 15,580 shares at $25.83 ($402,369)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operations Officer sold 2,253 shares at $24.37 ($54,912)
- 4 Open-market sale Chief Business Officer sold 7,435 shares at $24.60 ($182,901)
- 4 Grant or award Niedzwiecki Daniel acquired 9,093 shares (grant or award)
- 4 Grant or award Director acquired 8,513 shares (grant or award)
- 4 Grant or award Director acquired 8,513 shares (grant or award)
- 4 Grant or award Director acquired 8,513 shares (grant or award)
- 4 Grant or award Director acquired 8,513 shares (grant or award)
- 4 Grant or award Director acquired 8,513 shares (grant or award)
- 4 Grant or award Director acquired 8,513 shares (grant or award)
- 4 Grant or award Director acquired 8,513 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,139 shares (grant or award)
- 4 Open-market sale SVP and General Counsel sold 7,500 shares at $21.75 ($163,125)
- 4 Open-market sale President & CEO sold 19,421 shares at $20.66 ($401,277)
- 4 Open-market sale Director sold 2,800 shares at $21.22 ($59,416)
Page 15 of 30 · 599 filings